These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 3341023)
1. Nongenotoxicity of minoxidil in murine hair follicles as determined by the nuclear aberration assay. Schop RN; Goldberg MT Toxicol Appl Pharmacol; 1988 Jan; 92(1):150-4. PubMed ID: 3341023 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the activity of topically applied pesticides and the herbicide 2,4-D in two short-term in vivo assays of genotoxicity in the mouse. Schop RN; Hardy MH; Goldberg MT Fundam Appl Toxicol; 1990 Nov; 15(4):666-75. PubMed ID: 2086312 [TBL] [Abstract][Full Text] [Related]
3. Topical application of cyclosporin A induces rapid-remodeling of damaged anagen hair follicles produced in cyclophosphamide administered mice. Shirai A; Tsunoda H; Tamaoki T; Kamiya T J Dermatol Sci; 2001 Sep; 27(1):7-13. PubMed ID: 11457638 [TBL] [Abstract][Full Text] [Related]
4. Hair follicle biology and topical minoxidil: possible mechanisms of action. Headington JT Dermatologica; 1987; 175 Suppl 2():19-22. PubMed ID: 3319729 [TBL] [Abstract][Full Text] [Related]
5. The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years. Barbareschi M G Ital Dermatol Venereol; 2018 Feb; 153(1):102-106. PubMed ID: 29319278 [TBL] [Abstract][Full Text] [Related]
6. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia. Roberts J; Desai N; McCoy J; Goren A Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction. Meephansan J; Thummakriengkrai J; Ponnikorn S; Yingmema W; Deenonpoe R; Suchonwanit P Arch Dermatol Res; 2017 Nov; 309(9):729-738. PubMed ID: 28884378 [TBL] [Abstract][Full Text] [Related]
8. Nuclear aberrations in hair follicle cells of patients receiving cyclophosphamide. A possible in vivo assay for human exposure to genotoxic agents. Goldberg MT; Tackaberry LE; Hardy MH; Noseworthy JH Arch Toxicol; 1990; 64(2):116-21. PubMed ID: 2190540 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous effects of tocopheryl polyethylene glycol succinate (TPGS) on local hair growth promotion and systemic absorption of topically applied minoxidil in a mouse model. Chen CH; Sheu MT; Wu AB; Lin KP; Ho HO Int J Pharm; 2005 Dec; 306(1-2):91-8. PubMed ID: 16253450 [TBL] [Abstract][Full Text] [Related]
13. KF19418, a new compound for hair growth promotion in vitro and in vivo mouse models. Shirai A; Ikeda J; Kawashima S; Tamaoki T; Kamiya T J Dermatol Sci; 2001 Apr; 25(3):213-8. PubMed ID: 11240269 [TBL] [Abstract][Full Text] [Related]
14. Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata. Fiedler-Weiss VC J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):745-8. PubMed ID: 3549811 [TBL] [Abstract][Full Text] [Related]
15. Action of topical minoxidil in the bald stump-tailed macaque. Uno H; Cappas A; Brigham P J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):657-68. PubMed ID: 3558911 [TBL] [Abstract][Full Text] [Related]
16. Potential mechanisms of minoxidil-induced hair growth in alopecia areata. Fiedler-Weiss VC J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):653-6. PubMed ID: 3558910 [TBL] [Abstract][Full Text] [Related]
17. Doppler laser imaging predicts response to topical minoxidil in the treatment of female pattern hair loss. McCoy J; Kovacevic M; Situm M; Stanimirovic A; Bolanca Z; Goren A J Biol Regul Homeost Agents; 2016; 30(1):131-4. PubMed ID: 27049083 [TBL] [Abstract][Full Text] [Related]
18. The effect of topical minoxidil on hair follicular cycles of rats. Mori O; Uno H J Dermatol; 1990 May; 17(5):276-81. PubMed ID: 2380431 [TBL] [Abstract][Full Text] [Related]